{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T13:07:16Z","timestamp":1779541636376,"version":"3.53.1"},"reference-count":48,"publisher":"Central Research Institute for Epidemiology","issue":"2","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["virusjour.crie.ru"],"crossmark-restriction":false},"short-container-title":["Problems of Virology"],"abstract":"<jats:p>Objective. To evaluate how influenza infection affects the hypolipidemic effect of a novel combined drug \u2013 Prenophytol based on polyisoprenoids (sodium polyprenyl phosphate and beta-sitosterol) in mice with experimental dyslipidemia.\r\nMaterials and methods. In BALB\/c mice with experimentally induced dyslipidemia, the impact of Prenophytol on lipid metabolism parameters was assessed. Currently the drug is at the stage of clinical trials (Roszdravnadzor's permission to conduct clinical trials No. 362 dated 08\/14\/2025). A subset of animals was infected with influenza A\/California\/07\/2009 (H1N1) virus.\r\nResults. Administration of the drug to dyslipidemia mice resulted in a significant reduction in total cholesterol, triglycerides, and LDL levels, along with a significant increase in HDL. However, in the presence of influenza infection, the hypolipidemic effect of Prenophytol was markedly attenuated: only cholesterol levels decreased significantly, whereas changes in triglycerides, LDL, and HDL did not reach statistical significance.\r\nConclusions. Influenza infection diminishes the therapeutic efficacy of the Prenophytol in the treatment of dyslipidemia. These findings indicate that concomitant viral infections must be taken into account when designing dyslipidemia treatment regimens and conducting clinical trials of this drug.<\/jats:p>","DOI":"10.36233\/0507-4088-343","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T16:12:15Z","timestamp":1778429535000},"page":"139-149","update-policy":"https:\/\/doi.org\/10.36233\/0372-9311-crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Influenza virus infection affects the efficacy of the treatment of dyslipidemia in mice with a polyisoprenoid-based drug"],"prefix":"10.36233","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7062-958X","authenticated-orcid":false,"given":"Evgeny A.","family":"Makiev","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology named after the Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0507-1935","authenticated-orcid":false,"given":"Tatyana N.","family":"Kozhevnikova","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology named after the Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-9783","authenticated-orcid":false,"given":"Alexander V.","family":"Pronin","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology named after the Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0601-7148","authenticated-orcid":false,"given":"Alexander N.","family":"Narovlyansky","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology named after the Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3091-5802","authenticated-orcid":false,"given":"Alexander V.","family":"Sanin","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology named after the Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4049-7907","authenticated-orcid":false,"given":"Irina V.","family":"Ganshina","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology named after the Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5268-1296","authenticated-orcid":false,"given":"Maxim M.","family":"Shmarov","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology named after the Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22004","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"ref1","unstructured":"INTERHEART: A Global Case-Control Study of Risk Factors for Acute Myocardial Infarction. Available at: https:\/\/medscape.com\/viewarticle\/489738#vp_2"},{"key":"ref2","unstructured":"Kalashnikova M.F. Metabolic syndrome: a modern view on concept, prevention methods and treatment. Effektivnaya farmakoterapiya. 2013; (55): 52\u201363. https:\/\/elibrary.ru\/sxmwzt (in Russian)"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Kumari R., Kumar S., Kant R. An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome. Diabetes Metab. Syndr. 2019; 13(4): 2409\u201317. https:\/\/doi.org\/10.1016\/j.dsx.2019.06.005","DOI":"10.1016\/j.dsx.2019.06.005"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Vona R., Gambardella L., Cittadini C., Straface E., Pietraforte D. Biomarkers of oxidative stress in metabolic syndrome and associated diseases. Oxid. Med. Cell. Longev. 2019; 2019; 8267234. https:\/\/doi.org\/10.1155\/2019\/8267234","DOI":"10.1155\/2019\/8267234"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Zhou Y., Pu J., Wu Y. The role of lipid metabolism in influenza A virus infection. Pathogens. 2021; 10(3): 303. https:\/\/doi.org\/10.3390\/pathogens10030303","DOI":"10.3390\/pathogens10030303"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Montone R.A., Camilli M., Calvieri C., Magnani G., Bonanni A., Bhatt D.L., et al. Exposome in ischaemic heart disease: beyond traditional risk factors. Eur. Heart J. 2024; 45(6): 419\u201338. https:\/\/doi.org\/10.1093\/eurheartj\/ehae001","DOI":"10.1093\/eurheartj\/ehae001"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Haidari M., Wyde P.R., Litovsky S., Vela D., Ali M., Cassels S.W., et al. Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice. Atherosclerosis. 2010; 208(1): 90\u20136. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.07.028","DOI":"10.1016\/j.atherosclerosis.2009.07.028"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Fatkhullina A.R., Peshkova I.O., Koltsova E.K. The role of cytokines in the development of atherosclerosis. Boichemistry (Mosc.). 2016; 81(11): 1358\u201370. https:\/\/doi.org\/10.1134\/s0006297916110134","DOI":"10.1134\/S0006297916110134"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Chen L., Hao G. The role of angiotensin-converting enzyme 2 in coronaviruses\/influenza viruses and cardiovascular disease. Cardiovasc. Res. 2020; 116(12): 1932\u20136. https:\/\/doi.org\/10.1093\/cvr\/cvaa093","DOI":"10.1093\/cvr\/cvaa093"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Peretz A., Azrad M., Blum A. Influenza virus and atherosclerosis. QJM. 2019; 112(10): 749\u201355. https:\/\/doi.org\/10.1093\/qjmed\/hcy305","DOI":"10.1093\/qjmed\/hcy305"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Nguen J.L., Yang W., Ito K., Matte T.D., Shaman J., Kinney P.L. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol. 2016; 1(3): 274\u201381. https:\/\/doi.org\/10.1001\/jamacardio.2016.0433","DOI":"10.1001\/jamacardio.2016.0433"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Andrade F.B., Gualberto A., Rezende C., Percegoni N., Gameiro J., Hottz E.D. The weight of obesity in immunity from influenza to COVID-19. Front. Cell. Infect. Microbiol. 2021; 11: 638852. https:\/\/doi.org\/10.3389\/fcimb.2021.638852","DOI":"10.3389\/fcimb.2021.638852"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Pronin A.V., Danilov L.L., Narovlyansky A.N., Sanin A.V. Plant polyisoprenoids and control of cholesterol level. Arch. Immunol. Ther. Exp. (Warsz). 2014; 62(1): 31\u20139. https:\/\/doi.org\/10.1007\/s00005-013-0253-y","DOI":"10.1007\/s00005-013-0253-y"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Sanin A.V., Pronin A.V., Narovlyansky A.N., Ozherelkov S.V., Sedov A.M. Phosphorilated polyprenols as universal agents of viral reproduction suppression. Biol. Bull. Rev. 2022; 12(6): 609\u201324. https:\/\/doi.org\/10.1134\/S207908642206007X","DOI":"10.1134\/S207908642206007X"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Ershov F.I., Pronin A.V., Sanin A.V., Narovlyansky A.N. The combination of traditional therapy of genital herpes with immunotherapy: experience of using domestic immunotherapeutic drugs. Uspekhi sovremennoi biologii. 2020; 140(3): 263\u201377. https:\/\/doi.org\/10.31857\/S0042132420030047 https:\/\/elibrary.ru\/tuqlhx (in Russian)","DOI":"10.31857\/S0042132420030047"},{"key":"ref16","unstructured":"Narovlyansky A.N., Pronin A.V., Sanin A.V., Sedov A.M., Ershov F.I., Veselovsky V.V., et al. Isoprenoids: Polyprenols and Polyprenyl Phosphates as Physiologically Important Metabolic Regulators. Nova Science Publishers, INC.; 2018."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Zhou B.X., Li J., Liang X.L., Pan X.P., Hao Y.B., Xie P.F., et al. \u03b2-sitosterol ameliorates influenza A virus-induced proinflammatory response and acute lung injury in mice by disrupting the cross-talk between RIG-I and IFN\/STAT signaling. Acta Pharmacol. Sin. 2020; 41(9): 1178\u201396. https:\/\/doi.org\/10.1038\/s41401-020-0403-9","DOI":"10.1038\/s41401-020-0403-9"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Khan S.L., Siddiqui F.A. Beta-sitosterol: as immunostimulant, antioxidant and inhibitor of SARS-CoV-2 spike glycoprotein. Arch. Pharmacol. Ther. 2020; 2(1): 12\u20136. https:\/\/doi.org\/10.33696\/Pharmacol.2.014","DOI":"10.33696\/Pharmacol.2.014"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Palmer W.K., Emeson E.E., Johnston T.P. The poloxamer 407-induced hyperlipidemic atherogenic animal model. Med. Sci. Sports Exerc. 1997; 29(11): 1416\u201321. https:\/\/doi.org\/10.1097\/00005768-199711000-00005","DOI":"10.1097\/00005768-199711000-00005"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Matrosovich M., Matrosovich T., Garten W., Klenk H.D. New low-viscosity overlay medium for viral plaque assays. Virol. J. 2006; 3: 63. https:\/\/doi.org\/10.1186\/1743-422x-3-63","DOI":"10.1186\/1743-422X-3-63"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Sedova E.S., Stepanova L.A., Lysenko A.A., Shcherbinin D.N., Verkhovskaya L.V., Tsybalova L.M., et al. A study of the immunogenicity and protective properties of recombinant influenza vaccine. Molekulyarnaya genetika, mikrobiologiya i virusologiya. 2020; 38(3): 136\u201344. https:\/\/doi.org\/10.17116\/molgen202038031136 https:\/\/elibrary.ru\/mmnuvs (in Russian)","DOI":"10.17116\/molgen202038031136"},{"key":"ref22","unstructured":"Kuritz T. Methods and compositions for modulation of innate immunity. Patent US \u2116 0306017; 2009."},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Jeong A., Suazo K.F., Wood W.G., Distefano M.D., Li L. Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer\u2019s disease. Crit. Rev. Biochem. Mol. Biol. 2018; 53(3): 279\u2013310. https:\/\/doi.org\/10.1080\/10409238.2018.1458070","DOI":"10.1080\/10409238.2018.1458070"},{"key":"ref24","unstructured":"Pronin A.V., Narovlyanskii A.N., Deryabin P.G., Deeva A.V., Orlova N.G., Grigor\u2019eva E.A., et al. Antiviral effect of Phosprenyl in case of influenza infection. Veterinariya i kormlenie. 2005; (6): 25. (in Russian)"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Sanin A.V., Deryabin P.G., Narovlyansky A.N., Pronin A.V., Kozhevnikova T.N. Antiviral activity of Phosprenyl and Gamapren against infection caused by influenza A (H5N1) virus in cell culture. Voprosy virusologii. 2017; 62(4): 168\u201373. https:\/\/doi.org\/10.18821\/0507-4088-2017-62-4-168-173 https:\/\/elibrary.ru\/zfpbtj (in Russian)","DOI":"10.18821\/0507-4088-2017-62-4-168-173"},{"key":"ref26","unstructured":"Pronin A.V., Deeva A.V., Orlova N.G., Golovischenko K.A., Golovischenko A.A., Belousova R.V. Anti-influenzal effect of Phosprenyl in experiment and its application with the prophylactic purpose in conditions of a poultry factory. Rossiiskii veterinarnyi zhurnal. Sel\u2019skokhozyaistvennye zhivotnye. 2005; (3): 31\u20134. https:\/\/elibrary.ru\/oeedjz (in Russian)"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Santos-Marcos J.A., Perez-Jimenez F., Camargo A. The role of diet and intestinal microbiota in the development of metabolic syndrome. J. Nutr. Biochem. 2019; 70: 1\u201327. https:\/\/doi.org\/10.1016\/j.jnutbio.2019.03.017","DOI":"10.1016\/j.jnutbio.2019.03.017"},{"key":"ref28","unstructured":"Bouic P.J., Lamprecht J.H. Plant sterols and sterolins: a review of their immune-modulating properties. Altern. Med. Rev. 1999; 4(3): 170\u20137."},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Liu R., Hao D., Xu W., Li J., Li X., Shen D., et al. \u03b2-Sitosterol modulates macrophage polarization and attenuates rheumatoid inflammation in mice. Pharm. Biol. 2019; 57(1): 161\u20138. https:\/\/doi.org\/10.1080\/13880209.2019.1577461","DOI":"10.1080\/13880209.2019.1577461"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Bouic P.J. Sterols and sterolins: new drugs for the immune system? Drug Discov. Today. 2002; 7(14): 775\u20138. https:\/\/doi.org\/10.1016\/s1359-6446(02)02343-7","DOI":"10.1016\/S1359-6446(02)02343-7"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Li H., Zhao X., Wang J., Dong Y., Meng S., Li R., et al. \u03b2-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection. Sci. Rep. 2015; 5: 17668. https:\/\/doi.org\/10.1038\/srep17668","DOI":"10.1038\/srep17668"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Sanin A.V., Ganshina I.V., Sudiyna G.F., Sanina V.Yu., Kozhevnkova T.N., Pronin A.V., et al. Phosphorilated polyprenols \u2013 a novel class of compounds with anti-inflammatory and bronchial spasmolytic activity. Infektsiya i immunitet. 2011; 1(4): 355\u201360. https:\/\/doi.org\/10.15789\/2220-7619-2011-4-355-360 https:\/\/elibrary.ru\/nxerxt (in Russian)","DOI":"10.15789\/2220-7619-2011-4-355-360"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Loizou S., Lekakis I., Chrousos G.P., Moutsatsou P. \u03b2-Sitosterol exhibits anti-inflammatory activity in human aortic endothelial cells. Mol. Nutr. Food Res. 2010; 54(4): 551\u20138. https:\/\/doi.org\/10.1002\/mnfr.200900012","DOI":"10.1002\/mnfr.200900012"},{"key":"ref34","unstructured":"Sanin A.V., Narovlyansky A.N., Pronin A.V., Kozhevnikova T.N., Sanina V.Yu., Agafonova A.D. Study of Phosprenyl antioxidant activity in various biological test systems. Rossiiskii veterinarnyi zhurnal. 2017; (10): 38\u201341. https:\/\/elibrary.ru\/zxxxyl (in Russian)"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Parvez M.K., Alam P., Arbab A.H., Al-Dosari M.S., Alhowiriny T.A., Alqasoumi S.I. Analysis of antioxidative and antiviral biomarkers \u03b2-amyrin, \u03b2-sitosterol, lupeol, ursolic acid in Guiera senegalensis leaves extract by validated HPTLC methods. Saudi Pharm. J. 2018; 26(5): 685\u201393. https:\/\/doi.org\/10.1016\/j.jsps.2018.02.022","DOI":"10.1016\/j.jsps.2018.02.022"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Johnston T.P. The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: a review of findings to date. J. Cardiovasc. Pharmacol. 2004; 43(4): 595\u2013606. https:\/\/doi.org\/10.1097\/00005344-200404000-00016","DOI":"10.1097\/00005344-200404000-00016"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Dyadyk A.I., Kugler T.E., Suliman Y.V., Zborovskyy S.R., Zdykhovskaya I.I. Statin adverse effects: mechanisms, diagnosis, prevention and management. Arkhiv\u2019\u2019 vnutrennei meditsiny. 2018; 8(4): 266\u201377. https:\/\/doi.org\/10.20514\/22266704-2018-8-4-266-276 https:\/\/elibrary.ru\/xvaonf (in Russian)","DOI":"10.20514\/2226-6704-2018-8-4-266-276"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Palmer W.K., Emeson E.E., Johnston T.P. Poloxamer 407-induced atherogenesis in the C57BL\/6 mouse. Atherosclerosis. 1998; 136(1): 115\u201323. https:\/\/doi.org\/10.1016\/s0021-9150(97)00193-7","DOI":"10.1016\/S0021-9150(97)00193-7"},{"key":"ref39","unstructured":"Wout Z.G., Pec E.A., Maggiore J.A., Williams R.H., Palicharla P., Johnston T.P. Poloxamer 407-mediated changes in plasma cholesterol and triglycerides following intraperitoneal injection to rats. J. Parenter. Sci. Technol. 1992; 46(6): 192\u2013200."},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Sasaki J., Otonari T., Sawayama Y., Hata S., Oshima Y., Saikawa T., et al. Double-dose pravastatin versus add-on ezetimibe with low-dose pravastatin - effects on LDL cholesterol, cholesterol absorption, and cholesterol synthesis in Japanese patients with hypercholesterolemia (PEAS study). J. Atheroscler. Thromb. 2012; 19(5): 485\u201393. https:\/\/doi.org\/10.5551\/jat.12013","DOI":"10.5551\/jat.12013"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Matvienko O.A., Lewis D.S., Swanson M., Arndt B., Rainwater D.L., Stewart J., et al. A single daily dose of soybean phytosterols in ground beef decreases serum total cholesterol and LDL cholesterol in young, mildly hypercholesterolemic men. Am. J. Clin. Nutr. 2002; 76(1): 57\u201364. https:\/\/doi.org\/10.1093\/ajcn\/76.1.57","DOI":"10.1093\/ajcn\/76.1.57"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Vanstone C.A., Raeini-Sarjaz M., Parsons W.E., Jones P.J. Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons. Am. J. Clin. Nutr. 2002; 76(6): 1272\u20138. https:\/\/doi.org\/10.1093\/ajcn\/76.6.1272","DOI":"10.1093\/ajcn\/76.6.1272"},{"key":"ref43","unstructured":"Perminova O.M., Vol\u2019sky N.N., Kudaeva O.T., Goiman E.V., Kozlov V.A. Dyslipidemia and Th1\/Th2 relationship at different stages of chronic \u201cgraft-versus-host\u201d reaction. Immunologiya. 2009; 30(6): 341\u20135. https:\/\/elibrary.ru\/kzsxjj (in Russian)"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Gupta A.K., Savapoulos C.G., Ahuja G., Hatzitolios A.I. Role of phytosterols in lipid-lowering: current perspectives. QJM. 2011; 104(4): 301\u20138. https:\/\/doi.org\/10.1093\/qjmed\/hcr007","DOI":"10.1093\/qjmed\/hcr007"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Bergamini E., Bizzarri R., Cavallini G., Cerbai B., Chiellini E., Donati A., et al. Ageing and oxidative stress: a role of dolichol in the antioxidant machinery of cell membranes? J. Alzheimers Dis. 2004; 6(2): 129\u201335. https:\/\/doi.org\/10.3233\/jad-2004-6204","DOI":"10.3233\/JAD-2004-6204"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Bonnans C., Levy B.D. Lipid mediators as agonists for the resolution of acute lung inflammation and injury. Am. J. Respir. Cell. Mol. Biol. 2007; 36(2): 201\u20135. https:\/\/doi.org\/10.1165\/rcmb.2006-0269tr","DOI":"10.1165\/rcmb.2006-0269TR"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Poeckel D., Funk C.D. The 5-lipoxygenase\/leukotriene pathway in preclinical models of cardiovascular disease. Cardiovasc. Res. 2010; 86(2): 243\u201353. https:\/\/doi.org\/10.1093\/cvr\/cvq016","DOI":"10.1093\/cvr\/cvq016"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Singh G., Gupta P., Rawat P., Puri A., Bhatia G., Maurya R. Antidyslipidemic activity of polyprenol from Coccinia grandis in high-fat diet-fed hamster model. Phytomedicine. 2007; 14(12): 792\u20138. https:\/\/doi.org\/10.1016\/j.phymed.2007.06.008","DOI":"10.1016\/j.phymed.2007.06.008"}],"container-title":["Problems of Virology"],"original-title":[],"link":[{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/viewFile\/16799\/1092","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/viewFile\/16799\/1092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T12:41:18Z","timestamp":1779540078000},"score":1,"resource":{"primary":{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/view\/16799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,5,8]]}},"URL":"https:\/\/doi.org\/10.36233\/0507-4088-343","relation":{},"ISSN":["2411-2097","0507-4088"],"issn-type":[{"value":"2411-2097","type":"electronic"},{"value":"0507-4088","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}